Table 3 Comparison between the two treatment groups regarding the number of cases achieving a minimum of 50% reduction, and the absolute reduction in different migraine severity parameters
From: The role of left prefrontal transcranial magnetic stimulation in episodic migraine prophylaxis
| Â | Active (n = 13) [absolute reduction] | Placebo (n = 16) [absolute reduction] | p value |
|---|---|---|---|
Migraine attack frequency [number of attacks] | 9(69.2%) [3.1] | 4(25%) [1.5] | 0.02 |
Migraine days [number of days] | 9 (69.2%) [3.8] | 5(31.2%) [2.8] | 0.048 |
Severe migraine days [number of days] | 11 (84.6%) [5.7] | 8 (50%) [3.3] | 0.058 |
NPRS [score difference] | 3(23%) [2.1] | 1(6.25%) [1.3] | 0.2 |
Single attack duration [h] | 3(23%) [2.7] | 1(6.25%) [2.6] | 0.19 |
Use of abortive pills [number of pills] | 6(46.2%) [6] | 5(32.2%) [5.9] | 0.3 |